TFRC and hepatocellular carcinoma: To identify the binding protein of sVASN, we previously adopted an immunoprecipitation (IP) assay combined with mass spectrometry (MS) to capture the binding proteins of sVASN in HepG2 hepatocellular carcinoma cell lysates and identified CD71 as a candidate binding protein (Supplementary Figure S1A).